Loading AETHER price...
Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 31 Jul 2026), sales rose 52.4% from a year earlier to Rs 327 cr and profit rose 56.3% to Rs 62.7 cr.
- Return on equity stayed under 10% from FY24 to FY26 (highest 8.7%).
- Operations used cash in FY26 (-Rs 145 cr) while reported profit was Rs 230 cr.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 14 results, the share rose on 7 and fell on 7, and moved by 3% or more on 7.
Q1 FY27: results filed 31 Jul 2026. The share went from its close on 30 Jul 2026 to its close on 3 Aug 2026 +1.25%.
Of every Rs 100 of sales in FY26, Rs 69 went on running costs, Rs 5.8 on depreciation, Rs 1.5 on interest and Rs 6.3 on tax; Rs 19 was left as profit.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | - | 40.2% | 32.6% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | - | 22.1% | 28.7% | 31.5% |
| Net marginProfit after everything, per Rs 100 of sales. | - | 13.8% | 18.9% | 19.1% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 4.0% | 7.1% | 8.7% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 14.0% | 5.6% | 9.8% | 12.2% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.00x | 0.08x | 0.09x | 0.18x |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | - | 13.9x | 17.5x | 18.1x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 3,201 Cr of assets. Its owners funded 77% of that and borrowings 14%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -145 Cr, spent Rs 91 Cr on plant and equipment, and cash fell by Rs 233 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PIDILITIND Pidilite Industries Limited | 1.50 L cr | 56.9x | 13.9x | 24.2% | 28.5% | 0.01 | 17.4% | +21.3% | 1.01% |
| SRF SRF Limited | 69,362 cr | 30.4x | 4.5x | 14.9% | - | 0.34 | 12.5% | +34.7% | 0.38% |
| FLUOROCHEM Gujarat Fluorochemicals Limited | 46,168 cr | 75.4x | 5.9x | 7.7% | 10.2% | 0.28 | 11.5% | +24.0% | 0.07% |
| NAVINFLUOR Navin Fluorine International Limited | 39,306 cr | 49.8x | 9.9x | 19.9% | 18.7% | 0.31 | 21.7% | +44.1% | 0.17% |
| DEEPAKNTR Deepak Nitrite Limited | 19,676 cr | 25.1x | 3.4x | 13.3% | 10.8% | 0.26 | 9.1% | +36.4% | 0.52% |
| AETHER Aether Industries Limited | 19,529 cr | 82.8x | 8.0x | 9.6% | 12.2% | 0.18 | 19.2% | +52.4% | 0.00% |
| ATUL Atul Limited | 15,762 cr | 20.4x | 2.4x | 11.8% | - | 0.02 | 11.3% | +20.9% | 0.47% |
| AARTIIND Aarti Industries Limited | 15,539 cr | 29.3x | 2.6x | 8.9% | 8.5% | 0.83 | 5.9% | +42.5% | 0.23% |
| FINEORG Fine Organic Industries Limited | 15,328 cr | 35.0x | 5.8x | 16.4% | 20.2% | 0.02 | 17.7% | +18.0% | 0.22% |
| BASF BASF India Limited | 13,174 cr | 20.5x | 3.3x | 16.3% | 13.1% | 0.00 | 4.0% | +24.5% | 0.66% |
| PRIVISCL Privi Speciality Chemicals Limited | 13,109 cr | 49.4x | 9.3x | 23.7% | 25.1% | 0.70 | 12.8% | +19.2% | 0.15% |
| ANURAS Anupam Rasayan India Limited | 12,802 cr | 73.1x | 3.8x | 4.9% | 7.5% | 0.39 | 8.9% | +34.8% | 0.12% |
| SUDEEPPHRM Sudeep Pharma Limited | 11,103 cr | 59.7x | 12.6x | 20.4% | 24.2% | 0.17 | 27.2% | - | 0.00% |
| VINATIORGA Vinati Organics Limited | 10,964 cr | 24.4x | 3.5x | 14.2% | 17.7% | 0.00 | 18.8% | +28.4% | 0.71% |
| JUBLINGREA Jubilant Ingrevia Limited | 9,581 cr | 31.2x | 3.1x | 9.9% | 10.8% | 0.25 | 6.6% | +25.3% | 0.83% |
| ALKYLAMINE Alkyl Amines Chemicals Limited | 8,373 cr | 37.2x | 5.5x | 14.7% | 14.6% | 0.00 | 13.6% | +30.2% | 0.61% |
| CLEAN Clean Science and Technology Limited | 7,835 cr | 33.6x | 5.0x | 14.7% | 19.2% | 0.00 | 23.7% | +10.5% | 0.81% |
| GALAXYSURF Galaxy Surfactants Limited | 7,710 cr | 21.8x | 2.8x | 12.9% | 12.7% | 0.06 | 6.2% | +39.4% | 0.27% |
| NEOGEN Neogen Chemicals Limited | 5,955 cr | 163.7x | 7.3x | 4.4% | 6.8% | 1.63 | 3.8% | +34.0% | 0.04% |
| BALAMINES Balaji Amines Limited | 5,882 cr | 28.7x | 3.0x | 9.8% | 10.2% | 0.06 | 13.8% | +27.2% | 0.61% |
| ACI Archean Chemical Industries Limited | 5,782 cr | 59.4x | 3.0x | 5.0% | 7.8% | 0.24 | 8.6% | +11.9% | 0.64% |
| YASHO Yasho Industries Limited | 4,542 cr | 78.8x | 10.2x | 13.0% | 11.3% | 1.22 | 6.1% | +54.9% | 0.01% |
| FOSECOIND Foseco India Limited | 4,285 cr | 42.6x | 4.0x | 9.4% | - | 0.00 | 13.2% | +47.2% | 0.37% |
| LXCHEM Laxmi Organic Industries Limited | 4,257 cr | 33.9x | 2.1x | 6.3% | 4.4% | 0.27 | 4.0% | +39.8% | 0.33% |
| EPIGRAL Epigral Limited | 3,820 cr | 14.1x | 1.7x | 12.2% | 14.8% | 0.25 | 10.3% | +16.3% | 0.48% |
| VISHNU Vishnu Chemicals Limited | 3,772 cr | 25.1x | 3.5x | 13.9% | 16.2% | 0.49 | 8.8% | +24.9% | 0.05% |
| TATVA Tatva Chintan Pharma Chem Limited | 3,667 cr | 71.3x | 4.7x | 6.6% | 7.6% | 0.15 | 9.2% | +43.0% | 0.06% |
| STYRENIX Styrenix Performance Materials Limited | 3,370 cr | 12.3x | 2.5x | 20.0% | 12.8% | 0.23 | 7.8% | +7.1% | 2.80% |
| CHEMPLASTS Chemplast Sanmar Limited | 3,009 cr | - | 1.7x | -22.3% | -4.1% | 1.11 | -9.2% | +2.3% | 0.00% |
| JUBLCPL Jubilant Agri and Consumer Products Limited | 2,910 cr | 22.7x | 6.3x | 28.2% | 34.9% | 0.06 | 6.6% | +18.4% | 0.00% |
| DDEVPLSTIK Ddev Plastiks Industries Limited | 2,473 cr | 11.6x | 2.4x | 21.1% | 28.9% | 0.05 | 6.7% | +28.6% | 0.94% |
| NOCIL NOCIL Limited | 2,420 cr | 36.7x | 1.4x | 3.7% | 4.1% | 0.00 | 4.8% | +19.9% | 1.40% |
| ROSSARI Rossari Biotech Limited | 2,251 cr | 14.9x | 1.7x | 11.3% | 15.3% | 0.31 | 5.9% | +28.2% | 0.12% |
| OAL Oriental Aromatics Limited | 2,114 cr | 647.5x | 3.2x | 0.8% | 6.2% | 0.61 | 0.5% | +15.2% | 0.08% |
| SHK S H Kelkar and Company Limited | 1,749 cr | 19.6x | 1.3x | 6.5% | 9.6% | 0.62 | 3.6% | +14.1% | 1.58% |
| CAMLINFINE Camlin Fine Sciences Limited | 1,600 cr | 378.6x | 1.5x | 0.1% | 2.9% | 0.67 | 0.0% | +22.7% | 0.00% |
| VIDHIING Vidhi Specialty Food Ingredients Limited | 1,557 cr | 29.2x | 4.8x | 16.2% | 20.9% | 0.18 | 12.1% | +66.4% | 1.45% |
| PAUSHAKLTD Paushak Limited | 1,501 cr | - | 3.1x | - | 8.7% | 0.16 | - | - | 0.40% |
| PLATIND Platinum Industries Limited | 1,242 cr | 24.6x | 2.8x | 10.8% | 14.9% | 0.01 | 11.1% | -5.6% | 0.00% |
| VALIANTORG Valiant Organics Limited | 1,221 cr | 22.5x | 1.6x | 7.2% | 7.0% | 0.33 | 7.1% | +13.3% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 22.1% to 31.5% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.